Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFDA sets hierarchy for biosimilars evidence.AuthorsRatner, MarkAbstractThe article focuses on the draft guidance issued by the U.S. Food and Drug Administration (FDA) on categorizing the clinical pharmological data of the biotech companies for the submission of biosimilars, biologic medical products.SubjectsUNITED States. Food &; Drug Administration; BIOTECHNOLOGY industriesPublicationNature Biotechnology, 2014, Vol 32, Issue 7, p609ISSN1087-0156Publication typeArticleDOI10.1038/nbt0714-609a